SEC Filings

Browse insider trades, institutional holdings, and ownership changes — straight from SEC EDGAR.

TypeCompanyDateSummaryStatus
4Acrivon Therapeutics, Inc.ACRVMay 18, 2026Processed
4Acrivon Therapeutics, Inc.ACRVMay 18, 2026Processed
4Acrivon Therapeutics, Inc.ACRVMay 18, 2026Processed
4Acrivon Therapeutics, Inc.ACRVMay 14, 2026Processed